These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39010726)

  • 21. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells.
    Zhang C; Guan R; Liao X; Ouyang C; Rees TW; Liu J; Chen Y; Ji L; Chao H
    Chem Commun (Camb); 2019 Oct; 55(83):12547-12550. PubMed ID: 31576841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. α-Diimines as Versatile, Derivatizable Ligands in Ruthenium(II) p-Cymene Anticancer Complexes.
    Biancalana L; Batchelor LK; Funaioli T; Zacchini S; Bortoluzzi M; Pampaloni G; Dyson PJ; Marchetti F
    Inorg Chem; 2018 Jun; 57(11):6669-6685. PubMed ID: 29790340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-Photon Photodegradation of E3 Ubiquitin Ligase Cereblon by a Ru(II) Complex: Inducing Ferroptosis in Cisplatin-Resistant Tumor Cells.
    Lin X; Zheng M; Xiong K; Wang F; Chen Y; Ji L; Chao H
    J Med Chem; 2024 May; 67(10):8372-8382. PubMed ID: 38745549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards targeting anticancer drugs: ruthenium(ii)-arene complexes with biologically active naphthoquinone-derived ligand systems.
    Kubanik M; Kandioller W; Kim K; Anderson RF; Klapproth E; Jakupec MA; Roller A; Söhnel T; Keppler BK; Hartinger CG
    Dalton Trans; 2016 Aug; 45(33):13091-103. PubMed ID: 27214822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New organometallic ruthenium(ii) complexes with purine analogs - a wide perspective on their biological application.
    Fandzloch M; Jędrzejewski T; Dobrzańska L; Esteban-Parra GM; Wiśniewska J; Paneth A; Paneth P; Sitkowski J
    Dalton Trans; 2021 Apr; 50(16):5557-5573. PubMed ID: 33908935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells.
    Pracharova J; Novohradsky V; Kostrhunova H; Štarha P; Trávníček Z; Kasparkova J; Brabec V
    Dalton Trans; 2018 Sep; 47(35):12197-12208. PubMed ID: 30112527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of 3D colon cancer stem cell spheroids by cytotoxic Ru
    Acharya S; Ghosh S; Maji M; Parambil ARU; Singh S; Mukherjee A
    Chem Commun (Camb); 2020 May; 56(40):5421-5424. PubMed ID: 32292957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulating the Anticancer Activity of Ruthenium(II)-Arene Complexes.
    Clavel CM; Păunescu E; Nowak-Sliwinska P; Griffioen AW; Scopelliti R; Dyson PJ
    J Med Chem; 2015 Apr; 58(8):3356-65. PubMed ID: 25812075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic hydrogen bridged ruthenium quinaldamide complexes showing induced cancer cell death by apoptosis.
    Lord RM; Allison SJ; Rafferty K; Ghandhi L; Pask CM; McGowan PC
    Dalton Trans; 2016 Aug; 45(33):13196-203. PubMed ID: 27417660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, characterization, HSA/DNA interactions and antitumor activity of new [Ru(η
    Đukić MB; Jeremić MS; Filipović IP; Klisurić OR; Kojić VV; Jakimov DS; Jelić RM; Onnis V; Matović ZD
    J Inorg Biochem; 2020 Dec; 213():111256. PubMed ID: 32980642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticancer activity and DNA binding of a bifunctional Ru(II) arene aqua-complex with the 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine ligand.
    Busto N; Valladolid J; Martínez-Alonso M; Lozano HJ; Jalón FA; Manzano BR; Rodríguez AM; Carrión MC; Biver T; Leal JM; Espino G; García B
    Inorg Chem; 2013 Sep; 52(17):9962-74. PubMed ID: 23957818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New organoruthenium compounds with pyrido[2',3':5,6]pyrazino[2,3-f][1, 10]phenanthroline: synthesis, characterization, cytotoxicity, and investigation of mechanism of action.
    Pavlović M; Nikolić S; Gligorijević N; Dojčinović B; Aranđelović S; Grgurić-Šipka S; Radulović S
    J Biol Inorg Chem; 2019 Mar; 24(2):297-310. PubMed ID: 30762123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and characterisation of new chimeric ruthenium(II)-gold(I) complexes as improved cytotoxic agents.
    Massai L; Fernández-Gallardo J; Guerri A; Arcangeli A; Pillozzi S; Contel M; Messori L
    Dalton Trans; 2015 Jun; 44(24):11067-76. PubMed ID: 25996553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Cytostatic Ruthenium(II)-Platinum(II) Bis(terpyridyl) Anticancer Complex That Blocks Entry into S Phase by Up-regulating p27(KIP1).
    Ramu V; Gill MR; Jarman PJ; Turton D; Thomas JA; Das A; Smythe C
    Chemistry; 2015 Jun; 21(25):9185-97. PubMed ID: 25950156
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Gopalakrishnan D; Saravanan S; Merckx R; Madan Kumar A; Khamrang T; Velusamy M; Vasanth K; Sunitha S; Hoogenboom R; Maji S; Ganeshpandian M
    Dalton Trans; 2021 Jun; 50(23):8232-8242. PubMed ID: 34037018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
    Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
    J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ru(phen)
    Li R; Ma Y; Hu X; Wu W; Wu X; Dong C; Shi S; Lin Y
    Dalton Trans; 2020 Jul; 49(26):8864-8871. PubMed ID: 32602487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes.
    Grozav A; Balacescu O; Balacescu L; Cheminel T; Berindan-Neagoe I; Therrien B
    J Med Chem; 2015 Nov; 58(21):8475-90. PubMed ID: 26488797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative solution equilibrium studies of antitumor ruthenium(η
    Dömötör O; Pape VFS; May NV; Szakács G; Enyedy ÉA
    Dalton Trans; 2017 Mar; 46(13):4382-4396. PubMed ID: 28287667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.